Patent Board Must Revisit Rejected Application, Federal Circuit Says
WASHINGTON, D.C. — A decision by the Patent Trial and Appeal Board that upheld an examiner’s rejection of an application to patent a way of improving cholesterol efflux activity was vacated...To view the full article, register now.
Already a subscriber? Click here to view full article